In this episode of "Driving Digital in Biopharma," host Tom Lehmann welcomes Morrey Atkinson, the Chief Technology and Operations Officer at Vertex Pharmaceuticals. With a rich background in process development and manufacturing within the pharmaceutical industry, Morrey shares his insights on Vertex's strategic evolution and its commitment to serial innovation through substantial investments in R&D. They discuss the company's modality-agnostic approach, which allows flexibility in tackling various diseases, as well as covering the strategic use of contract development and manufacturing organizations (CDMOs) to optimize Vertex's global manufacturing footprint, ensuring rapid and reliable delivery of therapies to patients worldwide.
Listeners will gain a comprehensive understanding of how Vertex Pharmaceuticals leverages digital innovation to maintain its leadership in drug development and manufacturing, setting new standards in the biopharma industry.